1. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global strategy for the diagnosis, management and prevent of chronic obstructive pulmonary disease [Internet]. GOLD;2011. cited 2012 Feb 22. Available from:
http://www.goldcopd.org.
2. World Health Organization. The global burden of disease. 2004 update. Geneva: World Health Organization;2008.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349:1498–1504.
4. Hwang YI, Yoo KH, Sheen SS, Park JH, Kim SH, Yoon HI, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the result of Forth Korean National Health and Nutrition Examination Survey. Tuberc Respir Dis. 2011; 71:328–334.
6. Hwang YI, Kwon OJ, Kim YW, Kim YS, Park YB, Lee MG, et al. Awareness and impact of COPD in Korea: an epidemiologic insight survey. Tuberc Respir Dis. 2011; 71:400–407.
7. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009; 18:208–215.
8. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34:648–654.
9. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011; 38:29–35.
10. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011; 105:57–66.
12. Kim YS, Byun MK, Jung WY, Jeong JH, Choi SB, Kang SM, et al. Validation of the Korean version of the St. George's Respiratory Questionnaire for patients with chronic respiratory disease. Tuberc Respir Dis. 2006; 61:121–128.
13. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005; 8:94–104.
14. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54:581–586.
15. Lee S, Lee JS, Song JW, Choi CM, Shim TS, Kim TB, et al. Validation of the Korean version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT) and Dyspnea-12 Questionnaire. Tuberc Respir Dis. 2010; 69:171–176.
16. Park MJ, Choi CW, Kim SJ, Kim YK, Lee SY, Kang KH, et al. Survey of COPD management among the primary care physicians in Korea. Tuberc Respir Dis. 2008; 64:109–124.
17. The COPD Assessment Test: healthcare professional user guide: expert guidance on frequently asked questions [Internet]. Brentford: GlaxoSmithKline;c2009. cited 2012 Feb 22. Available from:
http://www.catestonline.co.uk/.
18. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, et al. Tests of the responsiveness of the COPD Assessment Test following acute exacerbation and pulmonary rehabilitation. Chest. 2012; 142:134–140.
19. AACR. Confronting COPD in America: executive summary [Internet]. Philadelphia: American Association for Cancer Research;cited 2012 Feb 22. Available from:
http://www.aacr.org/.